.svg | CAS_number = 50-07-7 | ATC_prefix = L01 | ATC_suffix = DC03 | ATC_supplemental = | PubChem = 5746 | DrugBank = APRD00284 |C = 15 |H = 18 |N = 4 |O = 5 | molecular_weight = 334.327 g/mol | bioavailability = | protein_bound = | metabolism = Hepatic| elimination_half-life = 8-48 min | pregnancy_category = D (Au, U.S.)| legal_status = ℞-only (U.S.), POM (UK)| routes_of_administration = Exclusively intravenous}} The mitomycins are a family of aziridine-containing natural products isolated from Streptomyces lavendulae. One of these compounds, mitomycin C, finds use as a chemotherapeutic agent by virtue of its antitumour antibiotic activity. It is given intravenously to treat upper gastro-intestinal (e.g. esophageal carcinoma) and breast cancers, as well as by bladder instillation for superficial bladder tumours. It causes delayed bone marrow toxicity and therefore it is usually administered at 6-weekly intervals. Prolonged use may result in permanent bone-marrow damage. It may also cause lung fibrosis and renal damage.

Mitomycin - Familydoctor.org - Information for patients in English and Spanish.
| Ex-player kills legendary coach Ed Thomas | |